Literature DB >> 8460004

Ocular evaporation in meibomian gland dysfunction and dry eye.

W D Mathers1.   

Abstract

BACKGROUND: Secretions from the meibomian gland are believed to be important in reducing ocular surface water evaporation and preventing dry eye. Patients with blepharitis frequently have meibomian gland dysfunction with loss of meibomian glands (drop out). The authors hypothesized that dry eye that often occurs in patients with chronic blepharitis is secondary to increased evaporation associated with gland loss.
METHODS: The authors measured the ocular surface water evaporation and tear osmolarity of patients with meibomian gland drop out and patients with gland drop out with a low Schirmer test. These findings were compared with those of a control group.
RESULTS: The authors found that eyes with meibomian gland drop out and those with drop out and a low Schirmer test had a significantly higher evaporative rate at 30% relative humidity (average, 49.9 +/- 21 x 10(-7) g/cm2/second, or 0.49 +/- 0.29 microliters/minute evaporative loss per eye, and 59.1 +/- 28 x 10(-7) g/cm2/second, or 0.58 +/- 0.23 microliters/minute, respectively) when compared with those in the control group (average, 14.8 +/- 6 x 10(-7) g/cm2/second, or 0.15 +/- 0.07 microliters/minute [P < 0.05]). There was a significant correlation between evaporative rate and gland drop out (r = 0.522).
CONCLUSION: Patients with meibomian gland drop out, and especially those with low tear production by Schirmer test, have an increased risk of dry eye developing through increased evaporation.

Entities:  

Mesh:

Year:  1993        PMID: 8460004     DOI: 10.1016/s0161-6420(93)31643-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  66 in total

1.  Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study.

Authors:  Gary N Foulks; Douglas Borchman; Marta Yappert; Shelley Kakar
Journal:  Cornea       Date:  2013-01       Impact factor: 2.651

2.  The use of fluorescent quenching in studying the contribution of evaporation to tear thinning.

Authors:  Jason J Nichols; P Ewen King-Smith; Erich A Hinel; Miru Thangavelu; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-20       Impact factor: 4.799

3.  Efficacy of diagnostic criteria for the differential diagnosis between obstructive meibomian gland dysfunction and aqueous deficiency dry eye.

Authors:  Reiko Arita; Kouzo Itoh; Syuji Maeda; Koshi Maeda; Atsuo Tomidokoro; Shiro Amano
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

4.  Characterization of Meibomian gland innervation in the cynomolgus monkey (Macaca fascicularis).

Authors:  W Kirch; M Horneber; E R Tamm
Journal:  Anat Embryol (Berl)       Date:  1996-04

Review 5.  Lacritin and other autophagy associated proteins in ocular surface health.

Authors:  Roy Karnati; Venu Talla; Katherine Peterson; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2015-08-25       Impact factor: 3.467

Review 6.  Interventions for chronic blepharitis.

Authors:  Kristina Lindsley; Sueko Matsumura; Elham Hatef; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

7.  Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study.

Authors:  P Prabhasawat; N Tesavibul; N Kasetsuwan
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

Review 8.  Lacritin and the tear proteome as natural replacement therapy for dry eye.

Authors:  Roy Karnati; Diane E Laurie; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2013-06-12       Impact factor: 3.467

9.  Meibography: A review of techniques and technologies.

Authors:  Ryan J Wise; Rachel K Sobel; Richard C Allen
Journal:  Saudi J Ophthalmol       Date:  2012-10

10.  [Meibomian glands : part IV. Functional interactions in the pathogenesis of meibomian gland dysfunction (MGD)].

Authors:  E Knop; N Knop
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.